Hubei Xiaogan Manufacturing Site
Porton acquired this site in 2021. Covering a total area of 221,200 square meters, it is dedicated to the research, development, and production of pharmaceutical intermediates.
No.1 Fazhan Road, Changjiangbu District, Yingcheng, Hubei
2013Years
546m3Total Capacity
Capability
- ISO Site
- Primary IM
- API Starting Material
- Grignard, Bromination, c-c coupling, Cyanidation etc
- Temperature Range (-70~140℃)
- Flow Chemistry
Services
Small Molecule
Small Molecule
Porton offers efficient, flexible, and high-quality solutions for custom development and production of small molecule APIs, as well as technical services throughout the entire lifecycle from pre-clinical to commercial to our worldwide partners.
One Porton One Quality
Compliance standards, Continuous improvement, Customer oriented
Quality management runs throughout the entire process of the drug life cycle. The quality management system of the drug product site is built in accordance with international standards and continues to adhere to the quality concept of 'more well-established system, more controllable quality.' This ensures that the GMP activities of the drug product site meet the requirements of international quality management systems and market drug regulatory agencies, including those of China, the European Union, FDA, and other mainstream regulations.
News
MoreNews2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
More
News2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
More
News2024-10-14
Driving innovation and excellence in the CDMO industry, Porton Pharma Solutions 2024 CPHI Europe Review
More
News2024-10-10
Connect with Porton J-STAR at AAPS PharmSci 360 2024 @ Booth 2431
More
